Article
Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae.
Genetics - 6 May 2026
Durand Romain, Torbey Alexandre G, Giguere Mathieu, Pageau Alicia, Dubé Alexandre K, Lagüe Patrick, Landry Christian R
Abstract excerpt
One of the front-line drug classes used to treat invasive fungal infections is echinocandins, which target the fungal-specific beta-glucan synthase (Fks). Treatment failure due to resistance often coincides with mutations in 3 protein regions defined as hotspots. Unfortunately, the scarcity of the mutational data reported, combined with the large size and membrane-embedded nature of the enzyme hinder any effort...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
